Ozagrel Sodium TCI O0660

Ozagrel Sodium (TCI O0660, CAS 189224-26-8) is a chemical compound widely used in life science research, particularly in biochemical and pharmaceutical studies. It serves as an enzyme inhibitor, specifically targeting thromboxane A2, a key mediator in blood clotting processes. This compound plays a crucial role in understanding and manipulating biological pathways related to hemostasis and vascular diseases. Its presence in laboratories is essential for studies involving enzyme inhibition and biochemical reactions that require precise control over biological processes.

Ozagrel Sodium is valued for its chemical stability under specific conditions and its solubility in organic solvents, which makes it highly versatile for various experimental applications. Its consistent performance and reliable results make it a preferred choice for researchers aiming for reproducibility and accuracy in their experiments. The compound’s ability to inhibit specific enzymes without significant side effects further enhances its appeal in both academic and industrial research settings.

In Indonesian laboratories, Ozagrel Sodium is commonly used in vascular disease research, particularly in studies related to thrombosis and coagulation disorders. Its role in simulating and analyzing the effects of enzyme inhibition on blood clotting mechanisms makes it an essential tool for scientists working in biochemistry and pharmacology. Researchers rely on its predictable behavior and high purity to ensure the reliability of their experimental outcomes.

• Used in thrombosis research to study the inhibition of thromboxane A2, which is critical in understanding blood clot formation.
• Applied in biochemical experiments to analyze enzyme inhibition mechanisms and their impact on biological processes.
• Employed in pharmacological studies to develop and test new drugs targeting vascular diseases and coagulation disorders.
• Utilized in enzyme kinetics research to measure the effectiveness of enzyme inhibitors in modulating biological pathways.
• Integrated into drug development workflows to evaluate the efficacy of compounds in preventing or treating vascular-related conditions.

Ozagrel Sodium should be stored in a cool, dry environment, away from direct sunlight and sources of heat. It is recommended to keep the compound in a sealed container to prevent moisture absorption and contamination. Due to its chemical stability, it does not require refrigeration but should be protected from prolonged exposure to air. Laboratory personnel should handle the compound with care, using appropriate personal protective equipment such as gloves and safety goggles. When working with this material, it is important to follow standard laboratory safety protocols to ensure the integrity of the compound and the safety of the researchers. Proper labeling of storage containers is essential to avoid confusion and ensure safe handling during experiments.

—